Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-27

Clinical Trial Update: Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial update on rivaroxaban for symptomatic isolated distal deep vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Walter Ageno | Conditions: Deep Vein Thrombosis | Phase 3 | Status: UNKNOWN